Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve 1. Consider and adopt the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges that its Board of Directors will meet on Saturday, February 14, 2026 at 4:00 PM. The key agenda items include considering and adopting the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The Board will also review the Limited Review Reports from the Statutory Auditor for the same period. The trading window for insiders will remain closed until 48 hours after the results are publicly announced.
This is a routine regulatory filing ahead of the Q3 FY26 earnings announcement scheduled for February 14, 2026. Investors should wait for the actual results to assess any financial impact on the stock.